Search Within

Elisa De Stanchina

  1. "John Morris IV"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Cancer Biology and Genetics Program Faculty (7)
  3. Center for Hematologic Malignancies (7)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  5. Center for Pancreatic Cancer Research (7)
  6. Executive Committee, Center for Hematologic Malignancies (7)

More Groups

People
  1. John Morris IV (7)
  2. Scott Lowe (7)
  3. Yu-jui Ho (5)
  4. Amanda Kulick (4)
  5. Janelle Simon (4)
  6. Wei Luan (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (2)
  6. 2016 (1)
Publications
  1. Cancer Research (2)
  2. Cell (2)
  3. Nature (1)
  4. Nature Cancer (1)
  5. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Cell Press (2)
  3. National Academy of Sciences (1)
  4. Nature Publishing Group (1)
  5. Nature Research (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
    Journal Article

    Chibaya, L.; Murphy, K. C.; DeMarco, K. D.; Gopalan, S.; Liu, H.; Parikh, C. N.; Lopez-Diaz, Y.; Faulkner, M.; Li, J.; Morris, J. P. 4th; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets
    Journal Article

    Li, X.; Huang, C. H.; Sánchez-Rivera, F. J.; Kennedy, M. C.; Tschaharganeh, D. F.; Morris, J. P. 4th; Montinaro, A.; O'Rourke, K. P.; Banito, A.; Wilkinson, J. E.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • EZH2 blockade overcomes suppression of the proinflammatory senescence-associated secretory phenotype in the pancreas and drives NK cell-mediated pancreatic tumor responses
    Meeting Abstract

    Chibaya, L.; Lopez-Diaz, Y.; Liu, H.; Murphy, K. C.; Morris, J. P. 4th; Ho, Y. J.; Simon, J.; Luan, W.; Kulick, A.; Leang, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer
    Journal Article

    Ruscetti, M.; Morris, J. P. 4th; Mezzadra, R.; Russell, J.; Leibold, J.; Romesser, P. B.; Simon, J.; Kulick, A.; Ho, Y. J.; Fennell, M.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • Senescence induction triggers vascular remodeling and new vulnerabilities to chemo- and immunotherapy in pancreas cancer
    Meeting Abstract

    Ruscetti, M.; Morris, J. P. 4th; Mezzadra, R.; Russell, J.; Leibold, J.; Romesser, P. B.; Simon, J.; Kulick, A.; Ho, Y. J.; Fennell, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • p53 represses the mevalonate pathway to mediate tumor suppression
    Journal Article

    Moon, S. H.; Huang, C. H.; Houlihan, S. L.; Regunath, K.; Freed-Pastor, W. A.; Morris, J. P. 4th; Tschaharganeh, D. F.; Kastenhuber, E. R.; Barsotti, A. M.; Culp-Hill, R.; more...
    Cell (2019)

    Fulltext@MSK | Save
  • A combinatorial strategy for treating KRAS-mutant lung cancer
    Journal Article

    Manchado, E.; Weissmueller, S.; Morris, J. P.; Chen, C. C.; Wullenkord, R.; Lujambio, A.; de Stanchina, E.; Poirier, J. T.; Gainor, J. F.; Corcoran, R. B.; more...
    Nature (2016)

    Fulltext@MSK | Save